MESA+ NanoLab Acquires Eulitha PHABLE Photolithography System

EULITHA, a Swiss startup company offering innovative lithography equipment and services for the nanotechnology, photonics and optoelectronic markets announced today the delivery of its unique PhableR 100 photolithography tool to the MESA + NanoLab of the University of Twente in the Netherlands.

EULITHA PhableR 100 Photolithography System

The system incorporating Eulitha’s proprietary Displacement Talbot Lithography technology will enable researchers of this interdisciplinary research institute to perform high resolution lithography on different substrates without the severely limiting requirements such as flatness or conductivity one faces with previously available technologies.

MESA+ operates a 1250 m2 state-of-the-art NanoLab housing more than 200 items of advanced equipment that can be used to create an unlimited number of applications, and provide a variety of analysis methods and techniques. This makes it possible to realize excellent -interdisciplinary- research in the field of micro and nanotechnology. The cleanroom is available for researchers of the University of Twente, other institutes and for use by industrial partners; from small and medium enterprises to multinationals. Regarding the delivery of the system, Gerard Roelofs, head of MESA+ NanoLab said “We chose the PhableR 100 system due to its capability to print in the deep sub-micron range and versatility to print various patterns through an uncomplicated process. We expect users of our facility coming from many different fields of research to be able to take full advantage of this advanced lithography capability.”

The PhableR 100 system is capable of exposing periodic patterns down to feature sizes below 150nm which rivals high-end i-line steppers. The patented focus-free imaging technology used by the system enables uniform printing on non-flat samples often found in photonic and optoelectronic sectors. Christian Dais, head of photolithography equipment production at Eulitha, said "This order from a prestigious European research institution shows the potential of our innovative technology and equipment in a research setting. We will be collaborating closely with researchers at the NanoLab for the most effective use of our Displacement Talbot Lithography technology. We believe our system will prove to be an excellent alternative to costly steppers or complicated laser interference setups used by many institutions and companies for creating high-resolution periodic structures.” Eulitha had previously announced the sale of one of their lithography systems to a specialty optics production company based in China.

Eulitha AG is a spin-off company of the Paul Scherrer Institute, Switzerland. It specializes in the development of lithographic technologies for applications in optoelectronics and photonics. It produces and markets nano-patterned samples and templates using its own PHABLE tools and state-of-the-art e-beam lithography systems. PHABLE is a registered trade mark and the brand name of Eulitha's proprietary photolithography platform, which includes exposure tools and wafer patterning services.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Eulitha AG. (2019, February 11). MESA+ NanoLab Acquires Eulitha PHABLE Photolithography System. AZoNano. Retrieved on June 25, 2024 from

  • MLA

    Eulitha AG. "MESA+ NanoLab Acquires Eulitha PHABLE Photolithography System". AZoNano. 25 June 2024. <>.

  • Chicago

    Eulitha AG. "MESA+ NanoLab Acquires Eulitha PHABLE Photolithography System". AZoNano. (accessed June 25, 2024).

  • Harvard

    Eulitha AG. 2019. MESA+ NanoLab Acquires Eulitha PHABLE Photolithography System. AZoNano, viewed 25 June 2024,

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.